From the above we can clearly see that there is significant Value tied up in PAA's History as well as it's future , a Commercial Valuation would identify and establish a value for all of the IP that is in Pharmausts name and in Partnerships.

There was also a Royalty Payment from a project with Dr Morris if my memory is correct but happy to be corrected..

Another Company yesterday delivered news of entering into an MOU this is what has been lacking at PAA, to Forrmalise Discussions . It's just the natural progression of Business to move to formalise agreements... the below resulted in a 10% gain

4DMedical inks MOU with Philips to expand XV Technology sales in North America

Looking forward to the MND Updates as they come to hand but serious effort will be required to gain market cut through and be noticed,, like many Platforms even HC prioritises clients who participate with Paid Content ,, that's how the Platform remains free to us the users..

I'm sure the Announcement that MT has registered PAA's application for FDA Orphan Drug Designation when made will deliver a significant increase in Value as it signals to the market that PAA is serious and ready to move forward to Commercialisation..

Best of Luck for the Day ,, I'm closing out positions prior to Christmas as I'm expecting some Retail Investor Sell Offs.

Obviously Holding PAA as the proposed MND Trial Data will most likely be the biggest Catalyst since Covid skyrocketed the SP to 24c...